Table 3 Toxicity of pegylated liposomal doxorubicin in the studied patients
Event | All grades | Grade III/IV |
|---|---|---|
No (%) | No (%) | |
Non-hematological | ||
 PPE | 13 (33.3) | 4 (10.3) |
 Stomatitis | 8 (20.5) | 2 (5.1) |
 Mucositis | 6 (15.4) | 1 (2.6) |
 Diarrhea | 6 (15.4) | 2 (5.1) |
 Constipation | 2 (5.1) | 0 (0) |
 Anorexia | 4 (10.3) | 0 (0) |
 Nausea | 4 (10.3) | 0 (0) |
 Vomiting | 5 (12.8) | 0 (0) |
 Hypersensitivity | 5 (12.8) | 1 (2.6) |
 Fatigue | 4 (10.3) | 1 (2.6) |
 Alopecia | 3 (7.7) | 0 (0) |
 Cardiac toxicity | 2 (5.1) | 0 (0) |
Hematological | ||
 Anemia | 6 (15.4) | 2 (5.1) |
 Leukopenia | 4 (10.3) | 3 (7.7) |
 Neutropenia | 4 (10.3) | 2 (5.1) |
 Thrombocytopenia | 2 (5.1) | 0 (0) |